Reyataz (Atazanavir)

News
Article

Protease inhibitor for once-daily administration

Newsletter

Get the latest industry news, event updates, and more from Managed healthcare Executive.

Subscribe Now!
Recent Videos
Related Content
ICER Finds GLP-1 Drugs Cost-Effective but Warns of Major Budget Strain

ICER Finds GLP-1 Drugs Cost-Effective but Warns of Major Budget Strain

Denise Myshko
September 9th 2025
Article

Read More

David Calabrese of OptumRx Talks Top Three Drugs in Pipeline, Industry Trends in Q2

David Calabrese of OptumRx Talks Top Three Drugs in Pipeline, Industry Trends in Q2

Briana Contreras
September 9th 2025
Podcast

Listen

Peter Togel-stock@adobe.com

Teva Launches First Generic GLP-1 Drug for Obesity

Formulary Watch
September 9th 2025
Article

Read More

freebird7977-stock@adobe.com

Novo Nordisk Teams with Form Health, 9amHealth for Obesity Care

Denise Myshko
September 9th 2025
Article

Read More

olgakris-stock@adobe.com

Lilly’s Oral GLP-1 Meets Endpoints in Phase 3 Trial

Denise Myshko
September 9th 2025
Article

Read More

Ellen Kelsay-stock@adobe.com

Employers: Cancer, GLP-1 Drugs and Mental Health Driving Healthcare Costs

Denise Myshko
September 9th 2025
Article

Read More

© 2025 MJH Life Sciences

All rights reserved.